“ Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment ” (2014) Brazilian Journal of Pharmaceutical Sciences, 50(2), pp. 345–352. doi:10.1590/S1984-82502014000200014.